BioSpace News Archive

BioMidwest

Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem

Iterum Therapeutics plc today announced the United States Patent and Trademark Office has issued the Company a Notice of Allowance for U.S. patent application number 16/972,300.

September 19, 2022
·
5 min read
Business

Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back Pain

Aclarion, Inc. announced today their participation in the Biomarkers for Evaluating Spine Treatments (BEST) Trial funded through the Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM.

September 19, 2022
·
6 min read
Drug Development

Trevi Therapeutics Announces Positive Data from Full Set of Subjects in Phase 2 CANAL Trial of Haduvio™ in the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis

Trevi Therapeutics, Inc. today announced positive results from the full set of subjects in its Phase 2 Cough And NALbuphine (CANAL) trial of Haduvio for the treatment of chronic cough in IPF.

September 19, 2022
·
9 min read
BioCapital

Gain Therapeutics Presents New Preclinical Data Demonstrating Potential Disease Modifying Benefits of its Novel Brain Penetrant Small Molecule Candidate GT-02287 in Two Preclinical Models of Parkinson’s Disease

Gain Therapeutics, Inc. today announced the presentation of new preclinical data at the International Congress of Parkinson’s Disease and Movement Disorders 2022 Annual Meeting in Madrid, Spain.

September 19, 2022
·
8 min read
Genetown

Journal of Infusion Nursing Publishes Access Vascular Data Showing Significantly Reduced Complication Rates for HydroMID

Access Vascular, Inc. announced the outcome of a peer-reviewed study published in the Journal of Infusion Nursing that demonstrated a significant reduction in complications when using AVI’s consistently hydrophilic midline catheters.

September 19, 2022
·
3 min read
Deals

Ventyx Biosciences Announces $176.6 Million Private Placement of Common Stock

Ventyx Biosciences, Inc. announced today that it has entered into a stock purchase agreement for the sale of 5,350,000 shares of its common stock at an offering price of $33.00 per share.

September 19, 2022
·
5 min read
Biotech Beach

AmyriAD to Host a Key Opinion Leader Webinar on Alzheimer’s Disease Management

AmyriAD Therapeutics today announced that it will host a key opinion leader (KOL) webinar, entitled, “ Looking Beyond Amyloid for Alzheimer’s Disease.

September 19, 2022
·
3 min read
Business

Viracta Therapeutics Announces Chief Executive Officer Leadership Succession to Drive the Next Phase of the Company’s Strategic Development and Growth

Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer.

September 19, 2022
·
8 min read
Kamari Pharma Raises $8 Million from the Sino-Israeli GIBF2 Fund

Kamari Pharma announced today the completion of an $8 million investment by the Chinese fund GIBF2, managed by Dr. Shuki Gleitman, Prof. Shlomo Noy, Mr. Avner Lushi and Mr. Carl Geng.

September 19, 2022
·
2 min read
Revance Announces Two Publications Highlighting the Efficacy and Safety Profile of DAXXIFY™ (DaxibotulinumtoxinA-lanm) For Injection in the Aesthetic Surgery Journal

Revance Announces Two Publications Highlighting the Efficacy and Safety Profile of DAXXIFY ™ (DaxibotulinumtoxinA-lanm) For Injection in the Aesthetic Surgery Journal,

September 19, 2022
·
10 min read